Search alternatives:
marked decrease » marked increase (Expand Search)
positive group » positive role (Expand Search)
marked decrease » marked increase (Expand Search)
positive group » positive role (Expand Search)
-
1
-
2
-
3
-
4
Immunohistochemical analysis of p-Akt expression in various experimental groups showing negative expression in control group, marked increased expression along the extended fibrous bands (upper insert) in TAA group, significant dose-related decreased expression following the decreased fibroplasia in RBO treated groups, and limited expression in SIL treated group.
Published 2021“…<sup>a</sup> <i>P</i>≤0.05 was assumed to denote statistical significance compared to the negative control, <sup>b</sup> <i>P</i>≤0.05 was assumed to denote statistical significance compared to TAA group. …”
-
5
-
6
Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.
Published 2025“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”
-
7
-
8
Altered expression of genes related to Ca<sup>2+</sup> cycling or myocardial contraction.
Published 2025Subjects: -
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx
Published 2020“…</p><p>Conclusion: The acute psychotic state is marked by state-specific increases of immune markers and decreases in peripheral IDO pathway markers. …”
-
17
-
18
-
19
(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.
Published 2025Subjects: -
20